3-methyladenosine has been researched along with adenosine in 11 studies
| Studies (3-methyladenosine) | Trials (3-methyladenosine) | Recent Studies (post-2010) (3-methyladenosine) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
|---|---|---|---|---|---|
| 11 | 0 | 7 | 32,536 | 1,075 | 8,930 |
| Protein | Taxonomy | 3-methyladenosine (IC50) | adenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, SN; Sasisekharan, V | 1 |
| Ayres, K; Larson, K; Lindgren, V; Sklar, R; Strauss, B | 1 |
| Fujii, T; Nakasaka, T; Saito, T | 1 |
| Chen, XH; Jin, DZ; Shi, LH; Wang, J; Zhou, WC | 1 |
| Boldorini, R; Canonico, PL; Di Lisa, F; Drago, V; Galli, U; Genazzani, AA; Kaludercic, N; Maldi, E; Travelli, C; Tron, GC | 1 |
| Cheng, Y; Liu, D; Patel, R; Qin, ZH; Ren, X; Shih, IM; Wu, H; Yang, JM; Yap, KL; Zhang, L; Zhang, Y | 1 |
| Chetty, C; Dontula, R; Herbert, E; Khan, AA; Lakka, SS; Ozer, H; Pannuru, P | 1 |
| Berk, BD; Bretón-Romero, R; Duess, MA; Farb, MG; Feng, B; Fetterman, JL; Flint, N; Gokce, N; Hamburg, NM; Holbrook, M; Linder, EA; Shirihai, OS; Vita, JA | 1 |
| Fan, Y; Li, J; Ma, L; Sun, D; Wu, B; Zhang, Y | 1 |
| Huang, YP; Li, C; Tang, J; Yi, M; Zhang, Y; Zhao, S | 1 |
| Azad, S; Ji, X; Tan, X | 1 |
11 other study(ies) available for 3-methyladenosine and adenosine
| Article | Year |
|---|---|
Conformations of 3-methylpurine nucleosides: implications on the structure of DNA duplexes.
Topics: Adenosine; DNA; Methylation; Nucleic Acid Conformation; Purine Nucleosides | 1984 |
Regulation of the capacity for O6-methylguanine removal from DNA in human lymphoblastoid cells studied by cell hybridization.
Topics: Adenosine; Cell Fusion; Cell Line; Deoxyguanosine; DNA; Drug Resistance; Female; Humans; Hybrid Cells; Karyotyping; Lymphoma; Male; Methylnitronitrosoguanidine; Neoplasms, Experimental | 1982 |
3-Methyladenine nucleosides: their synthesis, ring opening, and glycosidic bond cleavage.
Topics: Adenosine; Deoxyadenosines; Glycosides; Indicators and Reagents; Methods | 1980 |
[Design and synthesis of 3'-methyl-furanonucleosides and their anti-tumor activities].
Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Cladribine; Drug Screening Assays, Antitumor; Humans; Molecular Structure | 2009 |
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells.
Topics: Acrylamides; Adenosine; Adenosine Triphosphate; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Autophagy-Related Protein 7; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Survival; Chloroquine; Cisplatin; Comet Assay; DNA Damage; Down-Regulation; Drug Synergism; Etoposide; Humans; Immunohistochemistry; L-Lactate Dehydrogenase; Neuroblastoma; Nicotinamide Phosphoribosyltransferase; Piperidines; Ubiquitin-Activating Enzymes | 2011 |
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Antineoplastic Agents, Alkylating; Autophagy; Cell Line, Tumor; Cell Survival; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; HMGB1 Protein; Humans; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Protein Transport; Repressor Proteins; RNA Interference; Sequestosome-1 Protein | 2012 |
miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells.
Topics: Adenosine; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 5; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; HMGB1 Protein; Humans; Medulloblastoma; MicroRNAs; Microtubule-Associated Proteins; Osteonectin; RNA Interference; RNA, Small Interfering | 2014 |
Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling.
Topics: Adenosine; Adult; Aged; Autophagy; Biomarkers; Case-Control Studies; Cell Separation; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelial Cells; Female; Humans; Macrolides; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction; Spermidine | 2016 |
Crosstalk between 6-OHDA-induced autophagy and apoptosis in PC12 cells is mediated by phosphorylation of Raf-1/ERK1/2.
Topics: Adenosine; Animals; Apoptosis; Autophagy; Cell Survival; Hydroxydopamines; MAP Kinase Signaling System; PC12 Cells; Phosphorylation; Proto-Oncogene Proteins c-raf; Rats; Receptor Cross-Talk | 2016 |
Oxymatrine Inhibits Homocysteine-Mediated Autophagy via MIF/mTOR Signaling in Human Umbilical Vein Endothelial Cells.
Topics: Adenosine; Alkaloids; Apoptosis; Autophagy; Caspase 3; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Quinolizines; RNA Interference; RNA, Small Interfering; Sequestosome-1 Protein; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2018 |
Hypoxic Preconditioning Protects SH-SY5Y Cell against Oxidative Stress through Activation of Autophagy.
Topics: Adenosine; Autophagy; Beclin-1; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Hydrogen Peroxide; Microtubule-Associated Proteins; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Sirolimus; Tumor Suppressor Protein p53 | 2018 |